Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
- DOI
- 10.1016/j.ophtha.2023.12.026
- Published
- 2024 Jun
- Container
- Ophthalmology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ophtha.2023.12.026,
title = {Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.},
author = {Wong TY and Haskova Z and Asik K and Baumal CR and Csaky KG and Eter N and Ives JA and Jaffe GJ and Korobelnik JF and Lin H and Murata T and Ruamviboonsuk P and Schlottmann PG and Seres AI and Silverman D and Sun X and Tang Y and Wells JA and Yoon YH and Wykoff CC and YOSEMITE and RHINE Investigators},
year = {2024},
journal = {Ophthalmology},
doi = {10.1016/j.ophtha.2023.12.026},
url = {https://doi.org/10.1016/j.ophtha.2023.12.026}
}RIS
TY - JOUR TI - Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials. AU - Wong TY AU - Haskova Z AU - Asik K AU - Baumal CR AU - Csaky KG AU - Eter N AU - Ives JA AU - Jaffe GJ AU - Korobelnik JF AU - Lin H AU - Murata T AU - Ruamviboonsuk P AU - Schlottmann PG AU - Seres AI AU - Silverman D AU - Sun X AU - Tang Y AU - Wells JA AU - Yoon YH AU - Wykoff CC AU - YOSEMITE and RHINE Investigators PY - 2024 JO - Ophthalmology DO - 10.1016/j.ophtha.2023.12.026 UR - https://doi.org/10.1016/j.ophtha.2023.12.026 ER -
APA
TY, W., Z, H., K, A., CR, B., KG, C., N, E., JA, I., GJ, J., JF, K., H, L., T, M., P, R., PG, S., AI, S., D, S., X, S., Y, T., JA, W., YH, Y., CC, W., & Investigators, Y. A. R. (2024). Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.. Ophthalmology. https://doi.org/10.1016/j.ophtha.2023.12.026
Source records
- pubmed · retrieved 2026-09-26T13:51:50.185Z
- europe-pmc · retrieved 2026-09-26T13:51:50.179Z
- hal · retrieved 2026-09-26T13:51:50.203Z